Scholarlink

<p>This study provides a comprehensive view of the dynamics of pharmaceutical sales trajectories within the United States market, drawing from extensive historical sales data covering 391 product launches from January 1, 2000 to December 31, 2023. We analyze key performance metrics including, but not limited to, peak annual sales volumes, time-to-peak measurements, and annual growth rates. In addition, we provide detailed segmentation analysis across multiple dimensions, including therapeutic areas, treatment modalities, company profiles, and regulatory designations. To our knowledge, in comparison to the published literature, our analysis constitutes the most systematically stratified survey of US pharmaceutical sales trajectories. Our analysis demonstrates significant variability in sales uptake patterns and highlights factors such as therapeutic context, modality type, sponsor characteristics, and regulatory pathways that influence these dynamics. The findings provide novel quantitative benchmarks and practical insights for biopharmaceutical forecasting and strategic decision-making.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Quantifying Market Trajectories: A Study of Pharmaceutical Sales Uptake Curves and Related Parameters

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月17日

查看全文
  • Irwin Tendler,
  • Shomesh Chaudhuri,
  • Chinmay Shukla,
  • Neil Kumar,
  • Andrew Lo

摘要

This study provides a comprehensive view of the dynamics of pharmaceutical sales trajectories within the United States market, drawing from extensive historical sales data covering 391 product launches from January 1, 2000 to December 31, 2023. We analyze key performance metrics including, but not limited to, peak annual sales volumes, time-to-peak measurements, and annual growth rates. In addition, we provide detailed segmentation analysis across multiple dimensions, including therapeutic areas, treatment modalities, company profiles, and regulatory designations. To our knowledge, in comparison to the published literature, our analysis constitutes the most systematically stratified survey of US pharmaceutical sales trajectories. Our analysis demonstrates significant variability in sales uptake patterns and highlights factors such as therapeutic context, modality type, sponsor characteristics, and regulatory pathways that influence these dynamics. The findings provide novel quantitative benchmarks and practical insights for biopharmaceutical forecasting and strategic decision-making.